Rabbit Monoclonal Antibody Global Market Report 2025
상품코드:1889548
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
토끼 단일클론 항체 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 8억 3,000만 달러로 평가되었고, 2025년에는 9억 2,000만 달러에 달할 것으로 추정되며, CAGR 10.1%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 질환의 유병률 상승, 표적 요법에 대한 수요 증가, 진단 용도에서 채용 확대, 항체 연구에 대한 정부 자금 증가, 면역학 및 종양학 분야에서의 용도 확대에 기인한 것으로 보입니다.
토끼 단일클론 항체 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 13억 3,000만 달러에 달할 것으로 예측되며, CAGR 9.7%로 성장할 전망입니다. 예측 기간의 성장은 맞춤형 의료에 대한 주목의 고조, 종양학 및 면역학 분야에서의 채용 확대, 바이오 의약품 파이프라인 확충, 바이오테크놀러지 기업 간 제휴 강화, 고특이성 치료제에 대한 수요 증가 등이 요인으로 됩니다. 예측 기간 주요 동향으로는 항체 공학의 기술적 진보, 이중특이적 항체 및 다특이성 항체의 혁신, 완전 인간형 토끼 단일클론 항체의 개발, 차세대 항체 플랫폼의 연구개발, 항체 발견에서 AI 및 자동화의 통합을 들 수 있습니다.
향후 수년간 토끼 단일클론 항체 시장의 성장은 만성 질환의 유병률 상승에 의해 견인될 것으로 예측됩니다. 만성 질환은 점진적으로 진행되고, 지속적인 의료 관리가 필요한 장기간의 건강 상태를 의미합니다. 이러한 질병 증가는 앉기 쉬운 생활 습관에 부분적으로 기인합니다. 장시간의 앉아있는 습관 및 신체 활동량의 감소는 심장병 및 당뇨병과 같은 위험을 증가시킵니다. 토끼 단일클론 항체는 질병 관련 단백질을 높은 특이성 및 친화도로 표적화함으로써 만성 질환 치료를 지원합니다. 치료 정밀도 향상, 오프 타겟 효과 최소화, 치료 효과 증진은 환자의 예후 개선 및 효율적인 창약에 기여합니다. 예를 들어 영국 정부 기관인 국민보건서비스(NHS)에 따르면 2024년 6월 현재 2023년에 일반 개업의에 등록된 환자 3,615,330명이 비당뇨병성 고혈당 및 전당뇨병으로 진단되었습니다. 이는 2022년 3,065,825명에서 18% 증가한 것으로 나타났습니다. 따라서 만성질환의 유병률 증가가 토끼 단일클론 항체 시장의 확대를 견인하고 있습니다.
토끼 단일클론 항체 시장의 주요 기업은 치료 효과 향상, 표적 특이성 강화, 면역원성 저감을 도모하기 위해 종 특이적 항체 개발 등의 첨단 플랫폼을 개발하고 있습니다. 종 특이적 항체 개발은 서로 다른 동물의 면역 시스템을 활용하여 어려운 약물 표적에 대한 고유한 결합 특성과 높은 친화도를 가진 항체를 생산합니다. 2024년 9월 캐나다에 본사를 둔 AI 구동형 바이오세라퓨틱 연구기술 기업인 ImmunoPrecise Antibodies Ltd.는 이 회사의 토끼 항체 플랫폼에서 현저한 진전을 보고했습니다. 이 회사의 B Cell Select 플랫폼은 자동화된 항체 발견 및 최적화 기술인 LENSai 인공지능 기술과 통합되어 종 특이적 항체에서 현저한 임상적 진전을 보였습니다. 이 자동화 및 AI 구동 분석의 조합은 천연 구조를 유지하면서 고친화성 토끼 단일클론 항체를 신속하게 확인합니다. 이 접근법은 임상 용도 효율 향상, 표적 검증 가속, 개발 기간 단축, 치료용 항체 프로그램에서 재현성의 향상을 실현합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 토끼 단일클론 항체 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 토끼 단일클론 항체 시장 : 성장률 분석
세계의 토끼 단일클론 항체 시장 실적 : 규모 및 성장(2019-2024년)
세계의 토끼 단일클론 항체 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 토끼 단일클론 항체 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 토끼 단일클론 항체 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
면역글로불린 G(IgG)
면역글로불린 M(IgM)
면역글로불린 A(IgA)
면역글로불린 E(IgE)
면역글로불린 D(IgD)
세계의 토끼 단일클론 항체 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
진단
치료제
연구
창약
면역조직화학
세계의 토끼 단일클론 항체 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제약기업
학술연구기관
진단실험실
수탁연구기관
바이오테크놀러지 기업
세계의 토끼 단일클론 항체 시장 : 면역글로불린 G(IgG) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
서브클래스 1 면역글로불린 G
서브클래스 2 면역글로불린 G
서브클래스 3 면역글로불린 G
서브클래스 4 면역글로불린 G
세계의 토끼 단일클론 항체 시장 : 면역글로불린 M(IgM) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
오량체 면역글로불린 M
단량체형 면역글로불린 M
세계의 토끼 단일클론 항체 시장 : 면역글로불린 A(IgA) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
혈청 면역글로불린 A
분비형 면역글로불린 A
세계의 토끼 단일클론 항체 시장 : 면역글로불린 E(IgE) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
알레르겐 특이적 면역글로불린 E
총 면역글로불린 E
세계의 토끼 단일클론 항체 시장 : 면역글로불린 D(IgD) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
막 결합형 면역글로불린 D
분비형 면역글로불린 D
제7장 지역별 및 국가별 분석
세계의 토끼 단일클론 항체 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 토끼 단일클론 항체 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
토끼 단일클론 항체 시장 : 경쟁 구도
토끼 단일클론 항체 시장 : 기업 프로파일
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Avantor Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Rad Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bio-Techne Corporation
Elabscience Biotechnology Inc.
GenScript Biotech Corporation
Takara Bio Inc.
Rockland Immunochemicals Inc.
Creative Biolabs Inc.
Bioss Antibodies Inc.
Cell Signaling Technology Inc.
MyBioSource Inc.
Boster Biological Technology Co. Ltd.
GeneTex Inc.
Proteintech Group Inc.
Santa Cruz Biotechnology Inc.
AvantGen Inc.
ImmunoWay Biotechnology Company
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
토끼 단일클론 항체 시장(2009년) : 새로운 기회를 제공하는 국가
토끼 단일클론 항체 시장(2009년) : 새로운 기회를 제공하는 부문
토끼 단일클론 항체 시장(2009년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Rabbit monoclonal antibody is a highly specific antibody produced from a single clone of rabbit B cells. It demonstrates strong affinity and can recognize small or conserved epitopes that are often difficult for mouse antibodies to detect. It is used for accurate detection, quantification, or targeting of specific proteins in research, diagnostic, and therapeutic applications.
The main types of rabbit monoclonal antibody include immunoglobulin G (IgG), immunoglobulin M (IgM), immunoglobulin A (IgA), immunoglobulin E (IgE), and immunoglobulin D (IgD). Immunoglobulin G (IgG) rabbit monoclonal antibody is a high affinity, antigen specific antibody derived from rabbit B cells and represents the predominant immunoglobulin class used for precise detection, diagnosis, and therapeutic purposes. It is applied in diagnostics, therapeutics, research, drug discovery, and immunohistochemistry, serving end users such as pharmaceutical companies, academic and research institutions, diagnostic laboratories, contract research organizations, and biotechnology companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The rabbit monoclonal antibody market research report is one of a series of new reports from The Business Research Company that provides rabbit monoclonal antibody market statistics, including rabbit monoclonal antibody industry global market size, regional shares, competitors with a rabbit monoclonal antibody market share, detailed rabbit monoclonal antibody market segments, market trends and opportunities, and any further data you may need to thrive in the rabbit monoclonal antibody industry. This rabbit monoclonal antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rabbit monoclonal antibody market size has grown rapidly in recent years. It will grow from $0.83 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing demand for targeted therapies, growing adoption in diagnostic applications, rising government funding for antibody based studies, and growing application in immunology and oncology.
The rabbit monoclonal antibody market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising adoption in oncology and immunology, growing biopharmaceutical pipeline expansion, increasing collaborations between biotech companies, and rising demand for high specificity therapeutic agents. Major trends in the forecast period include technological advancements in antibody engineering, innovations in bispecific and multispecific antibodies, development of fully human rabbit monoclonal antibodies, research and development in next generation antibody platforms, and integration of AI and automation in antibody discovery.
The rising prevalence of chronic diseases is expected to drive the growth of the rabbit monoclonal antibody market in the coming years. Chronic diseases are long-lasting health conditions that develop gradually and often require ongoing medical care. The increasing prevalence of these diseases is partly due to sedentary lifestyles, as extended periods of sitting and low physical activity increase the risk of conditions such as heart disease and diabetes. Rabbit monoclonal antibodies support chronic disease treatment by providing highly specific and high-affinity targeting of disease-associated proteins. They improve therapeutic precision, minimize off-target effects, and enhance treatment efficacy, contributing to better patient outcomes and more efficient drug development. For example, in June 2024, according to the National Health Service, a UK based government department, 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18 percent increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the rabbit monoclonal antibody market.
Major companies in the rabbit monoclonal antibody market are developing advanced platforms such as species-specific antibody development to improve therapeutic efficacy, enhance target specificity, and reduce immunogenicity. Species-specific antibody development involves using distinct animal immune systems to produce antibodies with unique binding characteristics and high affinity for challenging drug targets. In September 2024, ImmunoPrecise Antibodies Ltd., a Canada based AI-driven biotherapeutic research and technology company, reported significant progress in its rabbit antibody platforms. The species-specific antibody demonstrated notable clinical advancements through its B Cell Select platform integrated with LENSai artificial intelligence technology for automated antibody discovery and optimization. This combination of automation and AI-driven analytics rapidly identifies high-affinity rabbit monoclonal antibodies while maintaining native structures. The approach improves clinical translation efficiency, accelerates target validation, shortens development timelines, and enhances reproducibility in therapeutic antibody programs.
In September 2024, Leinco Technologies Inc., a US based biotechnology company, acquired QED Biosciences Inc. for an undisclosed amount. Through this acquisition, Leinco Technologies aims to expand its antibody capabilities and strengthen its presence in the research, diagnostic, and rabbit monoclonal antibody markets. QED Biosciences Inc. is a US based biotechnology company specializing in the development and supply of high-quality rabbit monoclonal antibodies.
Major companies operating in the rabbit monoclonal antibody market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Avantor Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Elabscience Biotechnology Inc., GenScript Biotech Corporation, Takara Bio Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Bioss Antibodies Inc., Cell Signaling Technology Inc., MyBioSource Inc., Boster Biological Technology Co. Ltd., GeneTex Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., AvantGen Inc., ImmunoWay Biotechnology Company
North America was the largest region in the rabbit monoclonal antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rabbit monoclonal antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the rabbit monoclonal antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rabbit monoclonal antibody market consists of sales of recombinant rabbit monoclonal antibodies, polyclonal-to-monoclonal conversion antibodies, isotype control antibodies, and phospho-specific rabbit monoclonal antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rabbit Monoclonal Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rabbit monoclonal antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rabbit monoclonal antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rabbit monoclonal antibody market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Immunoglobulin G (IgG); Immunoglobulin M (IgM); Immunoglobulin A (IgA); Immunoglobulin E (IgE); Immunoglobulin D (IgD)
2) By Application: Diagnostics; Therapeutics; Research; Drug Discovery; Immunohistochemistry
3) By End User: Pharmaceutical Companies; Academic And Research Institutions; Diagnostic Laboratories; Contract Research Organizations; Biotechnology Companies
Subsegments:
1) By Immunoglobulin G (IgG): Subclass 1 Immunoglobulin G; Subclass 2 Immunoglobulin G; Subclass 3 Immunoglobulin G; Subclass 4 Immunoglobulin G
2) By Immunoglobulin M (IgM): Pentameric Immunoglobulin M; Monomeric Immunoglobulin M
3) By Immunoglobulin A (IgA): Serum Immunoglobulin A; Secretory Immunoglobulin A
4) By Immunoglobulin E (IgE): Allergen Specific Immunoglobulin E; Total Immunoglobulin E
5) By Immunoglobulin D (IgD): Membrane Bound Immunoglobulin D; Secreted Immunoglobulin D
3. Rabbit Monoclonal Antibody Market Trends And Strategies
4. Rabbit Monoclonal Antibody Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Rabbit Monoclonal Antibody Growth Analysis And Strategic Analysis Framework
5.1. Global Rabbit Monoclonal Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Rabbit Monoclonal Antibody Market Growth Rate Analysis
5.4. Global Rabbit Monoclonal Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Rabbit Monoclonal Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Rabbit Monoclonal Antibody Total Addressable Market (TAM)
6. Rabbit Monoclonal Antibody Market Segmentation
6.1. Global Rabbit Monoclonal Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoglobulin G (IgG)
Immunoglobulin M (IgM)
Immunoglobulin A (IgA)
Immunoglobulin E (IgE)
Immunoglobulin D (IgD)
6.2. Global Rabbit Monoclonal Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Therapeutics
Research
Drug Discovery
Immunohistochemistry
6.3. Global Rabbit Monoclonal Antibody Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Academic And Research Institutions
Diagnostic Laboratories
Contract Research Organizations
Biotechnology Companies
6.4. Global Rabbit Monoclonal Antibody Market, Sub-Segmentation Of Immunoglobulin G (IgG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subclass 1 Immunoglobulin G
Subclass 2 Immunoglobulin G
Subclass 3 Immunoglobulin G
Subclass 4 Immunoglobulin G
6.5. Global Rabbit Monoclonal Antibody Market, Sub-Segmentation Of Immunoglobulin M (IgM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pentameric Immunoglobulin M
Monomeric Immunoglobulin M
6.6. Global Rabbit Monoclonal Antibody Market, Sub-Segmentation Of Immunoglobulin A (IgA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serum Immunoglobulin A
Secretory Immunoglobulin A
6.7. Global Rabbit Monoclonal Antibody Market, Sub-Segmentation Of Immunoglobulin E (IgE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergen Specific Immunoglobulin E
Total Immunoglobulin E
6.8. Global Rabbit Monoclonal Antibody Market, Sub-Segmentation Of Immunoglobulin D (IgD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Membrane Bound Immunoglobulin D
Secreted Immunoglobulin D
7. Rabbit Monoclonal Antibody Market Regional And Country Analysis
7.1. Global Rabbit Monoclonal Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Rabbit Monoclonal Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
